improvement in the group where health improved, despite a high mean score of 0.92 at baseline. Neither statistical significance nor moderate-large effect size was observed in mean changes among unchanged group. Responsiveness property of the EQ-5D utility score was generally satisfactory with respect to each health condition group. Conclusions EQ-5D is found to be able to capture positive changes, and responsive in detecting important clinical changes in the improved group of this AIS population.
Introduction
Adolescent idiopathic scoliosis (AIS) is the commonest spine deformity which has no known etiology [1, 2] . It is defined as a lateral curvature of the spine greater than 10° accompanied by vertebral rotation, presenting between 10 and 18 years of age [3] . Curve progression can occur depending on a number of risk factors, such as the curve magnitude at the initial presentation, which is suggested to be the most important predictor of long-term curve progression and behavior even beyond skeletal maturity [4] . Curve progression can lead to mental health concerns [5] with subsequent psychological issues and health-compromising behavior [6] . Interventions like bracing can span the entire pubertal period of these adolescents, and fusion surgery has a long-lasting effect that persists into adulthood [7] . Assessment of AIS patients' health-related quality of life (HRQoL) hence is an important factor that governs the outcome of interventions. To fully comprehend and interpret its longterm effect, HRQoL should not only be captured at a single timepoint, but also over time to gauge long-term outcomes.
Abstract
Purpose To test the responsiveness of the EuroQoL 5-dimension (EQ-5D) utility scores for adolescent idiopathic scoliosis (AIS). Methods A baseline sample of 227 AIS patients was recruited between August and October 2015, and was surveyed prospectively to 9-12 months follow-up. EQ-5D-5L utility scores were derived using a two-step approach: (1) cross-walking from five-level responses to three-level responses and (2) applying the EQ-5D-3L Chinese population value set. An anchor approach was adopted to assess the responsiveness of EQ-5D. Effect size statistics (standardized effect size and standardized response mean) and independent t test were used to assess the responsiveness, as well as to analyze the ability of measures to detect score changes with global health condition changes or discriminate between the worsened and unchanged/improved groups. Results Approximately two-thirds of follow-up patients (64.2%) reported no change in global health condition based on the self-reported health anchor, whilst 4.6 and 31.3% of patients rated worse and better in current health condition compared to baseline, respectively. In the subgroup where health worsened, EQ-5D utility scores were responsive to detect negative changes. EQ-5D utility scores had slight One of the commonly used utility scores is the EuroQoL 5-dimension 5-level (EQ-5D-5L) questionnaire, which is a valid, reliable, and sensitive generic measure to assess the HRQoL in AIS [8] . Despite having been previously validated and found to be an applicable outcome measure to be used in the local AIS population, the responsiveness of EQ-5D-5L has not been investigated. Responsiveness refers to the ability of a measure to detect clinically important changes in health over time [9] , and hence crucial for calculating quality-adjusted life-years (QALYs) in cost-utility analyses [10] . Cost-utility assessment of treatment interventions in AIS is necessary to evaluate long-term outcomes.
Therefore, we hypothesize that the EQ-5D-5L mapped to the EQ-5D-3L utility scores is responsive to worsened and improved health in AIS patients. The aim of this study is to evaluate the responsiveness of the EQ-5D instrument as a utility score for patients with AIS. This study is based on the global rating of change scale as an anchor, with calculation of effect size statistics among groups of patients with worsened, unchanged, and improved health condition.
Methods
This was a prospective study of AIS patients recruited from a scoliosis specialty clinic between August and October 2015. Ethics was approved by the local institutional review board. Consecutive sampling of AIS patients was performed at the initial visit and these subjects were surveyed at a follow-up of 9-12 months (between July and August 2016). Exclusion criteria included patients with non-idiopathic scoliosis (congenital/neuromuscular), who were illiterate and refused to participate. Patients who had given consent completed the EQ-5D-5L questionnaire [Hong Kong (traditional Chinese) EQ-5D-5L version] [11] at baseline in person at the clinic. The follow-up assessment was carried out in the form of a telephone interview conducted by single research personnel in random order. At follow-up interview, in addition to the EQ-5D-5L, the global rating of change scale was also completed. Subjects who were lost to follow-up were marked as defaulted. We planned for at least 50-100 samples as this was classified as good quality of evaluating responsive property as listed by the COSMIN checklist [12] .
Demographic data of the patients and clinical data at the time of the initial visit were collected. All questionnaires were completed prior to the clinic consultation. The spine surgeon who provided such consultation was unaware of this study and assessed radiographs as usual. Whole spine standing radiographs (both posteroanterior and lateral) were taken on the same day as the consultation for measuring the Cobb angle [13] . Scoliosis curves were classified by the modified Lenke classification [14] which included six curve types: type 1 (main thoracic), type 2 (double thoracic), type 3 (double major and thoracic curve larger than lumbar curve), type 4 (triple major), type 5 (thoracolumbar or lumbar curve), and type 6 (double major, thoracolumbar, or lumbar curve larger than thoracic curve). Treatment modalities at the initial visit were retrieved from medical records and were recorded as: undergoing observation management, bracing, bracing followed by surgery, and those who had the previous fusion surgery undergoing regular review.
EuroQoL 5-dimension 5-level (EQ-5D-5L)
The EQ-5D-5L has five domain scales (mobility, selfcare, usual activities, pain and discomfort, and anxiety and depression) and five levels for each domain. The EQ-5D-5L has five items, each digit in the five digit codes refers to the status of each dimension, ranging from 1 for no problem, to 5 for severe problem. Since the specific EQ-5D-5L value set/ tariff for our country is currently not available, we adopted a two-step indirect approach to estimate EQ-5D-5L scores similar to another study [15] . The first step was the application of an indirect interim mapping method [16] . The EQ-5D-5L response values were transformed to the EQ-5D-3L response values according to the transition probability matrix. Subsequently, the EQ-5D-3L responsive values were scored according to an EQ-5D-3L value set ranging from − 0.149 for the worst health status ('33333') to 1 for the full health ('11111') [17] . The Visual Analogue Scale (VAS) of the EQ-5D, in this case, had been omitted at the follow-up to avoid repetition and confusion, due to the introduction of the anchor item, which asked the patients to assess their own overall health condition over time.
Global rating of change scale
For this study, an anchor, being an external criterion, was used as the reference to indicate patient improvement or worsening [18] . As for the AIS population whose cost-utility analysis is usually based on longitudinal follow-up, it is desirable to test the responsiveness of a transformation of the EQ-5D using an anchor of patient-reported assessment of health change over time (either prospectively or retrospectively determined) to indicate those for whom change in health occurred [19] .
The global rating of change (GRC) scale was, therefore, set as an anchor. GRC is a single-item outcome measure for independent scoring of self-perceived improvement in a patient, widely used for musculoskeletal research [20] . At the end of the follow-up assessment following the administration of EQ-5D-5L, GRC scale was administered to ask patients about their overall health condition as compared to the baseline initial visit. The question posed was: "Compared to the first visit (9-12 months ago), how would you rate your overall health now?" The response was a seven-point Likert scale: 'extremely worse' (rating of − 3), 'worse' (rating of − 2), 'a little worse' (rating of − 1), 'the same' (rating of 0), 'a little better' (rating of + 1), 'better' (rating of + 2), and 'extremely better' (rating of + 3). Due to insufficient sample size in the three 'worse' subcategories, they were collapsed into a single 'worsened' subcategory. Similarly, collapse of three 'better' subcategories into a single 'better' subcategory was performed. The scale was then categorized into three meaningful health condition change groups: 'worsened' (rating from − 3 to − 1), 'unchanged' (rating of 0), and 'improved' (rating from + 1 to + 3).
Statistical analysis
Differences in baseline characteristics between patients who have followed-up and defaulted were compared using independent t test and Chi-squared test, where appropriate. These tests were carried out to test the indifference between the follow-up and defaulted subjects, so to eliminate any concerns of the sampling, response, and selection biases. Descriptive statistics including mean ± standard deviation (SD), ceiling and floor proportion of the EQ-5D-5L scores at baseline and follow-up assessments were reported.
The responsiveness of the EQ-5D instrument was assessed using the effect size statistics. The utility score difference between baseline and follow-up assessments was evaluated by standardized effect size (SES) and standardized response mean (SRM) separately for each group. The standard of SES and SRM was interpreted as trivial for values < 0.2, small for values ≥ 0.2 to < 0.5, moderate for values ≥ 0.5 to < 0.8, or large for values ≥ 0.8, according to commonly accepted criteria [21] . The change in health condition was categorized into meaningful change groups for utility score comparisons.
To detect score changes with global health condition changes or discriminate between meaningful change groups, independent t tests were performed to compare the utility score in patients with different groups of health condition changes. This enabled the assessment of the ability of the EQ-5D-5L instrument to match changes in utility score with health, and to discriminate among three groups of health conditions (worsened versus unchanged/improved; worsened/unchanged versus improved). All statistical analyses were conducted using STATA version 13.0. A P value of < 0.05 was considered as statistically significant. Multiple testing with Bonferroni correction was performed. 95% confidence intervals (CIs) were listed when appropriate.
Results
The baseline characteristics of all patients are shown in Table 1 . Out of a total of 227 patients recruited at baseline, 51 patients (22.5%) defaulted at follow-up assessment. At baseline, the majority of patients were female (74.9%), of mild or moderate curvature with Cobb angle of ≤ 40° (90.3%), and were under observation with regular followup (61.2%). For those who were prescribed bracing, 63% had already undergone bracing for at least 1 year or more. There were no significant differences in the characteristics of those who followed-up or defaulted except for the duration of bracing. Among the defaulted patients, 72.7% were patients with at least 1 year of bracing, who seemed more likely to default than patients with less than 1-year bracing (27.3%). However, there were changes in the responses within each of the five domain scales of the EQ-5D-5L when comparing scores at the follow-up with the baseline, as illustrated in Figs. 1 and 2 .
Baseline and follow-up of EQ-5D-5L utility scores are shown in Table 2 . Mean utility scores at baseline and follow-up assessments were 0.931 ± 0.113 and 0.942 ± 0.091, respectively, with insignificant mean change of 0.003 ± 0.120 over time. There was no floor effect for the EQ-5D-5L utility score at baseline and follow-up, but severe ceiling effects were observed. Table 3 shows distribution of the global rating of change scale. About two-thirds of follow-up patients (64.2%) reported no change in global health condition based on the selfreported health anchor, whilst 4.6 and 31.3% of patients rated worse and better in current health condition compared to baseline, respectively. Table 4 illustrates the mean changes and effect size statistics for each health condition change group. In the subgroup where health worsened, EQ-5D-5L utility scores were responsive to detect negative changes. For those with health improvement, EQ-5D-5L utility scores also had slight improvements despite an already high mean score of 0.92 at baseline. Neither statistical significance nor moderate-large effect size was observed with mean change in the unchanged group. Table 5 shows the mean difference in change between health groups. Mean change over time in the improved group was statistically different from the worsened (P = 0.033) and the worsened/ unchanged (P = 0.033) groups, whilst significant mean differences between improved/unchanged versus worsened group (P = 0.038) were observed.
Responsiveness property of the EQ-5D-5L utility score was generally satisfactory with respect to all health condition groups.
Discussion
AIS is the commonest spinal deformity that affects adolescents from puberty until skeletal maturity, but the lasting effects of the disorder can reach adulthood. Hence, with possible interventions spanning a long period of time, decisions for observation (actively monitoring) versus bracing or surgical interventions may vary over time. There are reports of relative differences in properties among disease-specific measures such as SRS-7 versus SRS-22 in AIS children Fig. 1 The 5-level response distribution (%) of five domains in EQ-5D-5L at baseline who had undergone spinal fusion, including their abilities in detecting changes in HRQoL measures preoperatively versus 1-year post-operation [22] . Similarly, reports of SRS-22 [23] and SRS-30 [24] changes 2 years after surgery and at 5 years [25] follow-up have also showed good reflection of HRQoL outcomes. However, it is still unknown how utility scores can assess the effect of scoliosis and its treatment outcomes on quality of life over time.
A recent study showed that the SRS-22 scores can be mapped onto EQ-5D-5L utility scores in AIS patients to generate cost-utility data [26] . However, this can only provide individual score sets without responsiveness Fig. 2 The 5-level response distribution (%) of five domains in EQ-5D-5L at 9-12 month follow-up. At follow-up, response 'Moderate problem' (in light green) completely diminished in the domains mobility, self-care, and usual activities, whereas increase in responses 'Slight problem' and 'Moderate problem' in discomfort was noted Table 4 Mean change, standardized effect size and standardized response mean of EQ-5D-5L utility scores by global rating of change scale SES standardized effect size, SRM standardized response mean, CI confidence interval, SD standard deviation a Higher scores represent a higher level of functioning or a better HRQOL information. This is the first study, to our best knowledge, that examines the responsiveness of EQ-5D in the AIS patients. We are in search of a generic instrument which can generate utility scores, not only permitting comparison between patient groups [27] , but is essential in cost-utility analyses for longitudinal cohorts. It is necessary to analyze this tool's responsiveness and its ability to detect any improvement or worsening in quality of life. The responsiveness of EQ-5D has been studied in stroke, breast cancer, and chronic obstructive pulmonary disease [28] [29] [30] ; however, it has not been tested in an AIS population. In this study, EQ-5D successfully captured positive and negative changes that match improvement or worsening of health as suggested by the SES and SRM. Furthermore, the SES was near 0 in the unchanged group verifying its accuracy in detecting change. The EQ-5D has been found to be reasonably responsive in the worsened group, with SES of 0.71, comparable to that of 0.69 in breast cancer patients, with both studies adopting a self-rated change in quality of life [29] . Change in EQ-5D utility scores was able to differentiate between each of the health condition groups derived from the self-reported health anchor, except for comparison between unchanged and worsened group (P = 0.216), as well as between improved and unchanged group (P = 0.185). The mean changes in EQ-5D scores were statistically different at a significant level between improved versus worsened, improved versus worsened/ unchanged, and improved/unchanged versus worsened groups. As generic instruments are designed to capture all aspects of HRQoL, they can provide a broader context by which to interpret the information about change in HRQoL [31] and QALYs in cost-utility analyses. Current results revealed that the ability of EQ-5D utility scores in detecting deterioration was better than detecting improvement, leading to the greater extent of QALYs loss in cost-utility analyses.
It may also be worthwhile to appreciate the changes within the five domain scales of EQ-5D-5L over time. These changes in various aspects can possibly contribute to the differences in the global health condition scale, given that the follow-up population was comprised of very similar characteristics except the 2.5% increase in patients braced less than 1 year from baseline. The changes in EQ-5D-5L included the complete diminishing of 'moderate problems' in the mobility, self-care and usual activity domains, whilst an increased proportion of patients shifted from 'moderate problem' to 'no problem' in the anxiety domain, despite a higher proportion of both 'slight problem' and 'moderate problem' with discomfort. The only aspect worsened was the discomfort at 9-12 month follow-up, whereas all other aspects had improved. How these five domains contributed to the worsened/improved/unchanged general health condition on the global health scale is of further interest, especially relating to different treatment modalities. The construct of the five domains enables EQ-5D-5L to be more receptive in detecting changes over time. In addition, EQ-5D-5L was able to still detect changes beyond the already very high ceiling effect at baseline, as reflected by the further increase in ceiling effect by 1.3% in the follow-up patients. High ceiling effect of EQ-5D-5L dimension might be in part explained by the generic nature of EQ-5D scale. This must take into consideration 64.2% of patients who reported 'the same' in the global health condition, with a total of 4.6% reporting 'a little worse' or 'worse', and a sum of 31.3% with a response of 'a little better', 'better', or 'extremely better'.
The limitations of this study include the use of an indirect interim mapping method for EQ-5D-5L, instead of a direct valuation approach as the value sets for EQ-5D-5L are still under development [32] . There were contrasting claims, however, that data sets generated by algorithm mapping method were found to be narrower than the time trade-off value sets [33] , whereas another study based on breast cancer data found a lack of differences including responsiveness of EQ-5D-5L scores by both approaches [34] . Another limitation was the different modes of conducting the EQ-5D-5L questionnaires at baseline and at follow-up, being filling up in person versus phone interview, respectively. This was due to the timing of follow-up visits not coinciding with the responsiveness timepoint and it was impractical to recall patients only for the questionnaire. Possible discrepancies between written and verbal interviews were minimized by having the same research personnel conduct all phone interviews, in a systematic manner by which all five levels of responses of the EQ-5D-5L were read out to the subjects before an answer was given. Nevertheless, differential modes of administration have not been shown to lead to significant differences in EQ-5D scores [35] . Moreover, future study can also be improved with the use of multiple independent anchors (e.g., clinician-based anchor, proxy-based anchor Table 5 Mean difference in change of EQ-5D-5L utility scores with 95% confidence interval on discriminating groups of global health condition CI confidence interval *Significant difference between groups with P value < 0.05 a Tested by Bonferroni correction versus patient-reported anchor) and to examine and confirm responsiveness across multiple samples. Despite the advantages of GRC scale being simple and widely used, weaknesses including less reliability and validity of single-item global rating of change scale were pointed out in the previous literature [20] . Of note, this study made prior assumptions that changes in health condition resulted from scoliosis. Variations in EQ-5D-5L utility scores may not fully represent changes in health condition as a direct result of scoliosis. There may also be variations with different types of scoliosis and ethnic groups which require further study. Nonetheless, this study has shown that the EQ-5D is successful in detecting changes in health of an AIS population, and can serve as the basis of larger sample-sized, longitudinal study in the AIS population in the future to detect any significant changes over time for treatment modality in details, as well as to detect long-term outcomes.
Conclusion
The EQ-5D utility score is found to be able to capture positive changes in HRQoL score in AIS patients, and responsive in detecting important clinical changes in improved group of scoliosis population. Future studies about responsiveness property of EQ-5D score with respect to health state deterioration are warranted.
